Health
Nanotechnology offers new hope for bowel cancer patients – Newswise
Bowel cancer is the second deadliest cancer in the world, killing almost 900,000 people in 2020. New research from Indian and Australian scientists suggests tha
Newswise — Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.
That’s the finding from Indian and Australian scientists who have undertaken the first study, using nanoparticles to target bowel cancer, the third most common cancer in the world and the second most deadliest.
The researchers have shown in animal experiments that nanoparticles containing the chemotherapy drug Capecitabine (CAP) attach…
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business11 hours agoDicker Data rides the AI trend to double digit growth
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland